Vaccines, blood, antisera, toxins and cultures in   North Korea

Exports In 2022, North Korea exported $6.32M in Vaccines, blood, antisera, toxins and cultures, making it the 79th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 11th most exported product in North Korea. The main destination of Vaccines, blood, antisera, toxins and cultures exports from North Korea are: Niger ($3.15M), Poland ($1.21M), Rwanda ($988k), United Kingdom ($855k), and Lebanon ($104k).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of North Korea between 2021 and 2022 were Niger ($3.15M), Poland ($1.21M), and Rwanda ($988k).

Imports In 2022, North Korea imported $2.1M in Vaccines, blood, antisera, toxins and cultures, becoming the 185th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 81st most imported product in North Korea. North Korea imports Vaccines, blood, antisera, toxins and cultures primarily from: Netherlands ($1.79M) and China ($311k).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for North Korea between N/A and 2022 were Netherlands ($1.79M) and China ($311k).